Solving COVID: August 19, 2020
Good news about immunity, the power of mask mandates, and more
- 1. New studies suggest lasting immunity to COVID-19, even in mild cases
- 2. Mask mandates appear to be paying off in Kansas, Alabama
- 3. Federal COVID-19 study to test a promising drug cocktail
- 4. New models suggest herd immunity threshold might be lower than we thought
- 5. FDA approves saliva-based coronavirus test viewed as 'major game changer'
1. New studies suggest lasting immunity to COVID-19, even in mild cases
Scientists have been seeing "encouraging signs of strong, lasting immunity" to COVID-19, including in people who only experienced mild symptoms. Antibodies that fight the virus, and B cells and T cells that recognize it, appear to persist months after the infection has faded. "This is exactly what you would hope for," says University of Washington immunologist Marion Pepper, who authored one of the recent studies. "All the pieces are there to have a totally protective immune response." Emory University immunologist Eun-Hyung Lee adds: "Yes, you do develop immunity to this virus, and good immunity to this virus. That's the message we want to get out there." At the same time, it's still not clear how long the immune responses might last, and the recent studies "do not demonstrate protection in action."
2. Mask mandates appear to be paying off in Kansas, Alabama
Kansas and Alabama have seen their coronavirus trends improve following mask mandates, The Wichita Eagle and AL.com report. One month after Alabama's mask order went into effect, coronavirus numbers are on the decline, whether it's the percentage of positive tests (which was down to 11.1 percent on Friday from a high of 16.7 percent on July 18), hospitalization, or the raw number of daily infections. Of course, social distancing and other hygiene measures have played a role, but the mask mandate — and, more importantly, compliance — seems to be paying off. Kansas provides an even clearer view of the effect masks have, since the data collected by the Eagle shows a contrast between counties that followed the statewide mask order and those that didn't. Overall, Kansas' rolling 7-day average of new infections is down from its peak in mid-July, and the pattern is reportedly holding true in 16 counties that adopted the mask order. In 89 counties without a mandate, cases have trended up recently.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Federal COVID-19 study to test a promising drug cocktail
Beta interferon, an anti-inflammatory drug that has already been approved for treatment of multiple sclerosis, is being paired with remdesivir in the latest phase of a federal coronavirus trial, The New York Times reports. The results of the study's second phase are still being evaluated — and scientists are hopeful. Beta interferon is already on the market, and has shown promise against the new coronavirus, killing it (along with the SARS and MERS coronaviruses) in lab studies. Additionally, tests in the United Kingdom and Hong Kong showed the drug performed better among COVID-19 patients than the placebo it was up against. Both those studies were too small to come away with anything definitive, but the U.S. trial should be large enough to get a better sense of its ability.
4. New models suggest herd immunity threshold might be lower than we thought
Some infectious disease experts are examining the "hopeful possibility" that far fewer people than initially thought need to get infected or immunized with COVID-19 to achieve herd immunity, The New York Times reports. Researchers assumed that herd immunity would be reached with 60 to 70 percent of a population infected. But new models suggest it could be reached at 50 percent infection or less. "Mathematically, it's certainly possible to have herd immunity at these very, very low levels," Carl Bergstrom, an infectious disease expert at the University of Washington, tells the Times. "Those are just our best guesses for what the numbers should look like," but "they're just exactly that, guesses." It's not clear any city or pocket of a city has sufficient immune people to thwart a second wave of COVID-19, but there may be parts of Mumbai, London, and New York that are close or have developed at least significant collective resistance.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
5. FDA approves saliva-based coronavirus test viewed as 'major game changer'
The Food and Drug Administration issued an emergency use authorization for the SalivaDirect COVID-19 diagnostic test developed by the Yale School of Public Health. The test analyzes saliva samples to rapidly determine whether a person is infected with the coronavirus and does not require any type of swab or specific collection device. It could be one of the first "major game changers in fighting the pandemic," said Andy Slavitt, a former acting administrator of the Centers for Medicare and Medicaid Services under the Obama administration. The testing process is easier and more affordable than other options — materials cost about $4, Slavitt said, and even when adding the cost of labor and overhead, its development is still cheaper than current tests. Because it's cheap and has a fast turnaround time, people will likely be able to get tested more frequently, which could increase diagnostic accuracy.
Create an account with the same email registered to your subscription to unlock access.
-
Solo travel: the 'ultimate indulgence in 2024'
The Week Recommends Why more of us are choosing to go on holiday on our own
By Adrienne Wyper, The Week UK Published
-
'Stormy Monday for Don'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
6 queer poets to read whenever but especially now
The Week Recommends April is National Poetry Month
By Scott Hocker, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
How Tehran became the world's nose job capital
Under the radar Iranian doctors raise alarm over low costs, weak regulation and online influence of 'Western beauty standards'
By Harriet Marsden, The Week UK Published
-
Africa's renewed battle against female genital mutilation
Under the radar Campaigners call for ban in Sierra Leone after deaths of three girls as coast-to-coast convoy prepares to depart
By Harriet Marsden, The Week UK Published
-
Argentina: the therapy capital of the world
Under the radar Buenos Aires natives go hungry to pay for psychoanalysis, amid growing instability, anxiety – and societal acceptance
By Harriet Marsden, The Week UK Published
-
Does declining birth rate spell doom for Britain?
Today's Big Question Ageing population puts pressure on welfare state, economy and fabric of society, while fertility is rising on populist agendas
By Harriet Marsden, The Week UK Published
-
How a new blood test could revolutionise sepsis diagnosis
The Explainer Early results from ongoing trial suggest faster identification of deadly condition is possible
By The Week Staff Published
-
Kush: the drug destroying young lives in West Africa
The Explainer There has been a sharp rise in young addicts in Sierra Leone, Guinea and Liberia
By Flora Neville, The Week UK Published